Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines
Wuhan General Group (China), Inc.
401 Ryland St. Ste 200-A, Reno, NV 89502
_______________________________
+27 (82) 413 5457
https://m2bio.co/
willem@m2bio.co
SIC - 2833 - Medicinal and botanicals
QuarterlyReport
For the Period Ending: 30 September 2021
(the "Reporting Period")
As of 30 September 2021, the number of shares outstanding of our Common Stock was: 50,999,662
As of 30 June 2021, the number of shares outstanding of our Common Stock was: 55,289,662
As of 31 December 2020, the number of shares outstanding of our Common Stock was: 51,605,160
Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934):
Yes: ☐ | No: ☒ |
Indicate by check mark whether the company's shell status has changed since the previous reporting period:
Yes: ☐ | No: ☒ |
Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:
Yes: ☐ | No: ☒ |
- "Change in Control" shall mean any events resulting in:
- Any "person" (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the "beneficial owner" (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company's then outstanding voting securities;
- The consummation of the sale or disposition by the Company of all or substantially all of the Company's assets;
- A change in the composition of the Board occurring within a two (2)-year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or
- The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 1 of 19 |
- Name and address(es) of the issuer and its predecessors (if any)
In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the dates of the name changes.
03/2007 Wuhan General Group (China) Inc formely United National Film Corp.
The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years; Please also include the issuer's current standing in its state of incorporation (e.g. active, default, inactive):
09/12/2006 Nevada Active
Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:
NONE
List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:
NONE
The address(es) of the issuer's principal executive office:
Unit 01, Mason's Press, 7 Ravenscraig Road, Woodstock, 7925, Cape Town, South Africa
The address(es) of the issuer's principal place of business:
Check box if principal executive office and principal place of business are the same address: ☒
Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?
Yes: ☐ | No: ☒ |
If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below:
N/A
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 2 of 19 |
2) | Security Information | |||
Trading symbol: | WUHN | |||
Exact title and class of securities outstanding: | Common | |||
CUSIP: | 982569105 | |||
Par or stated value: | 0.0001 | |||
Total shares authorized: | 150,000,000 | as of date: September 30, 2021 | ||
Total shares outstanding: | 50,999,662 | as of date: September 30, 2021 | ||
Number of shares in the Public Float2: | 16,333,204 | as of date: September 30,2021 | ||
Total number of shareholders of record: | 156 | as of date: September 30, 2021 |
All additional class(es) of publicly traded securities (if any):
Exact title and class of securities outstanding: | Preferred | ||
Par or stated value: | 0.0001 | ||
Total shares authorized: | 50,000,000 | as of date: September 30, 2021 | |
Total shares outstanding: | 15,000,000 | as of date: September 30, 2021 | |
Exact title and class of securities outstanding: | Warrants A | ||
Par or stated value: | 0.0001 | ||
Total shares authorized: | 3,000,000 | as of date: September 30, 2021 | |
Total shares outstanding: | 2,250,000 | as of date: September 30, 2021 | |
Exact title and class of securities outstanding: | Warrants B | ||
Par or stated value: | 0.0001 | ||
Total shares authorized: | 3,000,000 | as of date: September 30, 2021 | |
Total shares outstanding: | 710,000 | as of date: September 30, 2021 | |
Exact title and class of securities outstanding: | Warrants C | ||
Par or stated value: | 0.0001 | ||
Total shares authorized: | 3,000,000 | as of date: September 30, 2021 | |
Total shares outstanding: | 710,000 | as of date: September 30, 2021 | |
Exact title and class of securities outstanding: | Options A | ||
Par or stated value: | 0.0001 | ||
Total shares authorized: | 3,000,000 | as of date: September 30, 2021 | |
Total shares outstanding: | 1,000,000 | as of date: September 30, 2021 | |
Transfer Agent | |||
Name: | EQ Shareowner Services | ||
Phone: | 303-282-4800 | ||
Email: | Michaelie.Wingo@equiniti.com | ||
Address: | 1110 Centre Pointe Curve, Suite 101, Mendota Heights, MN 55120 |
- "Public Float" shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding (a "control person"), or any affiliates thereof, or any immediate family members of officers, directors and control persons.
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 3 of 19 |
Is the Transfer Agent registered under the Exchange Act?3 Yes: ☒ | No: ☐ |
- Issuance History
The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer's securities in the past two completed fiscal years and any subsequent interim period.
Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events.
A. Changes to the Number of Outstanding Shares
Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods: ☐
Shares Outstanding as of Second Most Recent | |||||||||||
Fiscal Year End: | *Right-click the rows below and select "Insert" to add rows as needed. | ||||||||||
Opening Balance | |||||||||||
Date 01/01/2019 | Common: 39,771,310 | ||||||||||
Preferred: 1,500,000 | |||||||||||
Warrant: | 0 | ||||||||||
Option: | 0 | ||||||||||
Date of | Transaction | Number of | Class of | Value of | Were the | Individual/ Entity | Reason for share | Restricted or | Exemption | ||
Transaction | type (e.g. new | Shares | Securities | shares | shares | Shares were | issuance (e.g. for | Unrestricted | or | ||
issuance, | Issued (or | issued | issued at | issued to | cash or debt | as of this | Registration | ||||
cancellation, | cancelled) | ($/per | a discount | (entities must | conversion) | filing. | Type. | ||||
shares | share) at | to market | have individual | -OR- | |||||||
returned to | Issuance | price at | with voting / | Nature of | |||||||
treasury) | the time | investment | Services | ||||||||
of | control | Provided | |||||||||
issuance? | disclosed). | ||||||||||
(Yes/No) | |||||||||||
03/01/2019 | New issuance | 2,500,000 | common | .004 | yes | Slingshot | debt conversion | Unrestricted | Exemption | ||
Marketing | |||||||||||
Solutions, LLC | |||||||||||
(Benjamin Barry) | |||||||||||
08/29/2019 | New issuance | 1,000,000 | common | .004 | yes | Slingshot | debt conversion | Unrestricted | Exemption | ||
Marketing | |||||||||||
Solutions, LLC | |||||||||||
(Benjamin Barry) | |||||||||||
09/23/2019 | New issuance | 1,500,000 | preferred | .0001 | no | Ramy Kamaneh | management | Restricted | Exemption | ||
09/23/2019 | New issuance | 6,000,000 | preferred | .0001 | no | Jeff Robinson | management | Restricted | Exemption | ||
- To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act.
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 4 of 19 |
09/23/2019 | New issuance | 6,000,000 | preferred | .0001 | no | Dr. Anna Morera | management | Restricted | Exemption |
Leralta | |||||||||
02/26/2020 | New issuance | 4,283,850 | common | .004 | yes | Slingshot | debt conversion | Unrestricted | Exemption |
Marketing | |||||||||
Solutions, LLC | |||||||||
(Benjamin Barry) | |||||||||
05/05/2020 | New issuance | 500,000 | common | .03 | no | StockVest (Art | Consulting | Restricted | Exemption |
Brent) | services | ||||||||
05/21/2020 | New issuance | 50,000 | common | .03 | no | William Selah | Consulting | Restricted | Exemption |
Abrams | services | ||||||||
09/29/2020 | New issuance | 100,000 | common | .10 | yes | Ronald Hargrove | Private Placement | Restricted | Exemption |
09/29/2020 | New issuance | 50,000 | common | .10 | yes | Robert Thomas | Private Placement | Restricted | Exemption |
Hooper | |||||||||
09/30/2020 | New issuance | 150,000 | common | .10 | yes | Clark Winkler | Private Placement | Restricted | Exemption |
10/01/2020 | New issuance | 75,000 | common | .10 | yes | Allen Robert Tripp | Private Placement | Restricted | Exemption |
10/01/2020 | New issuance | 125,000 | common | .10 | yes | Clyde L Blanchi | Private Placement | Restricted | Exemption |
10/01/2020 | New issuance | 200,000 | common | .10 | yes | John Walters | Private Placement | Restricted | Exemption |
10/02/2020 | New issuance | 100,000 | common | .10 | yes | Philip J | Private Placement | Restricted | Exemption |
Munschauer | |||||||||
10/07/2020 | New issuance | 50,000 | common | .10 | yes | Ted Vruggink | Private Placement | Restricted | Exemption |
10/08/2020 | New issuance | 150,000 | common | .10 | yes | Timothy Jay | Private Placement | Restricted | Exemption |
Nagelkirk | |||||||||
10/08/2020 | New issuance | 50,000 | common | .10 | yes | Taylor Blom | Private Placement | Restricted | Exemption |
10/15/2020 | New issuance | 75,000 | common | .10 | yes | Michael David | Private Placement | Restricted | Exemption |
Ware | |||||||||
12/09/2020 | New issuance | 350,000 | common | .10 | yes | Jeffrey J Krueger | Private Placement | Restricted | Exemption |
12/10/2020 | New issuance | 250,000 | common | .10 | yes | Brian Corday | Private Placement | Restricted | Exemption |
12/27/2020 | New issuance | 150,000 | common | .10 | yes | John Wolters | Private Placement | Restricted | Exemption |
12/27/2020 | New issuance | 125,000 | common | .10 | yes | Ronald Hargrove | Private Placement | Restricted | Exemption |
12/29/2020 | New issuance | 1,500,000 | common | .30 | yes | ThreeD Capital | Private Placement | Restricted | Exemption |
( Sheldon | |||||||||
Inwentash) | |||||||||
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 5 of 19 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
Wuhan General Group (China) Inc. published this content on 22 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 22 November 2021 04:23:01 UTC.